COVID-19 drug FabiFlu price reduced by 27%
New Delhi: Glenmark Pharmaceuticals has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1000 COVID patients that are prescribed with the oral…